Shares of First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT - Get Free Report) reached a new 52-week high during mid-day trading on Tuesday . The company traded as high as GBX 1,610.10 ($21.03) and last traded at GBX 1,610.10 ($21.03), with a volume of 6 shares changing hands. The stock had previously closed at GBX 1,600.37 ($20.90).
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Stock Performance
The stock has a 50-day moving average price of GBX 1,574.69 and a 200 day moving average price of GBX 1,507.33. The company has a quick ratio of 9.27, a current ratio of 9.42 and a debt-to-equity ratio of 0.04. The firm has a market capitalization of £4.77 billion and a price-to-earnings ratio of -1,467.00.
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Company Profile
(
Get Free Report)
Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content.
Featured Articles
Before you consider First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation wasn't on the list.
While First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.